Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06964308

Thoracoscopic Pleural Biopsy in Sohag University Hospital

This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag University Hospital

Sohag, Egypt

Location status: Recruiting

Location contact

Magdy M Amin, Professor

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
  • Age: Adults aged 18 years and older
  • Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.

Exclusion criteria

  • Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
  • Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
  • Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
  • Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
  • Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons.
  • Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.

Treatment and study plan

thoracoscopic pleural biopsy.

Procedure

This intervention aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.

Primary outcomes

  1. early postoperative follow up for thoracoscopic pleural biopsy in the management of pleural diseases.

    Time frame: 3 days after procedure

    return to daily activity

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed O Yehya, Resident

CONTACT

[email protected]

01146628670

essam A mokhtar, Professor

CONTACT

01011908152

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Thoracoscopic Pleural Biopsy, Sohag University Hospital

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 9, 2025
Registry last updated
May 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.